Overview

Study of Treatment Effects of Combination Therapy of Lucentis Plus Reduced Fluence PDT With Visudyne in Patients With Exudative AMD

Status:
Unknown status

Trial end date:
2010-10-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the benefits, if any, of combination therapy with Lucentis plus reduced fluence photodynamic therapy with Visudyne.

Phase:

N/A

Details

Lead Sponsor:

Barnes Retina Institute

Collaborator:

QLT Inc.

Treatments:

Ranibizumab
Verteporfin